Antihypertensive and Hemodynamic Properties of the New Beta Adrenergic Blocking Agent Timolol

Circulation - United States
doi 10.1161/01.cir.48.1.118
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Hemodynamic Effects of Tilisolol, a New .BETA.-adrenergic Blocking Agent With Vasodilating Property, and Doxazosin, a New .ALPHA.-adrenergic Blocking Agent, in Essential Hypertension.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1988English

Comparison of Hemodynamic Effects Between .BETA.-blocking Agents and a New Antianginal Agent, Diltiazem Hydrochloride.

Japanese Circulation Journal
1979English

Beta-Adrenergic Blocking Drugs and Thyroid Function.

BMJ
1977English

Metabolic Studies on CS-359, a New .BETA.-adrenergic Blocking Agent. I. Isolation and Identification of the Urinary Metabolites of CS-359.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1975English

Meta-Analysis of the Hemodynamic Properties of Antihypertensive Medications

ISRN Hypertension
2013English

Synthesis and Adrenergic .BETA.-blocking Activity of Some Propanolamine Derivatives.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1978English

Beta Adrenergic Blocking Drugs and the Borg Rating Scale of Perceived Exertion.

British Journal of Sports Medicine
Sports MedicinePhysical TherapySports ScienceSports TherapyOrthopedicsMedicineRehabilitation
1997English

The Action of Sympathomimetic Amines and a New Beta-Adrenergic Blocking Agent (4-(2-Hydroxy-3-Isopropylaminopropoxy)-Indole) on the Isolated Trachea of Guinea Pigs

The Japanese Journal of Pharmacology
1969English

Immediate Haemodynamic Effects of a Beta Adrenergic Blocking Agent-Propranolol-In Mitral Stenosis at Fixed Heart Rates.

Heart
Cardiovascular MedicineCardiology
1972English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy